{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:03Z","timestamp":1791357483852,"version":"4.3.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T00:00:00Z","timestamp":1471564800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s40263-016-0381-0","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T09:30:18Z","timestamp":1471599018000},"page":"1209-1218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The Psychiatric Inclusion and Exclusion Criteria in Placebo-Controlled Monotherapy Trials of Bipolar Depression: An Analysis of Studies of the Past 20\u00a0Years"],"prefix":"10.1007","volume":"30","author":[{"given":"Mark","family":"Zimmerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina Guzman","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Multach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia K.","family":"Rosenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Gazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,19]]},"reference":[{"key":"381_CR1","first-page":"89","volume":"13","author":"B Brauzer","year":"1973","unstructured":"Brauzer B, Goldstein BJ. Symptomic volunteers: another patient dimension for clinical trials. J Clin Pharmacol. 1973;13:89\u201398.","journal-title":"J Clin Pharmacol"},{"key":"381_CR2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1037\/0022-006X.53.4.552","volume":"53","author":"JS Breckenridge","year":"1985","unstructured":"Breckenridge JS, Zeiss AM, Breckenridge JN, Gallagher D, Thompson LW. Solicitations of elderly depressives for treatment outcome research: a comparison of referral sources. J Consult Clin Psychol. 1985;53:552\u20134.","journal-title":"J Consult Clin Psychol"},{"key":"381_CR3","first-page":"69","volume":"33","author":"CA Miller","year":"1997","unstructured":"Miller CA, Hooper CL, Bakish D. A comparison of patients with major depressive disorder recruited through newspaper advertising versus consultation referrals for clinical drug trials. Psychopharmacol Bull. 1997;33:69\u201373.","journal-title":"Psychopharmacol Bull"},{"key":"381_CR4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00004714-199606000-00009","volume":"16","author":"MH Rapaport","year":"1996","unstructured":"Rapaport MH, Zisook S, Frevert T, Seymour S, Kelsoe JR, Judd LJ. A comparison of descriptive variables for clinical patients and symptomatic volunteers with depressive disorders. J Clin Psychopharmacol. 1996;16:242\u20136.","journal-title":"J Clin Psychopharmacol"},{"key":"381_CR5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0364-7722(79)90006-7","volume":"3","author":"L Covi","year":"1979","unstructured":"Covi L, Lipman R, McNair D, Czerlinsky T. Symptomatic volunteers in multicenter drug trails. Neuropsychopharmacol. 1979;3:521\u201333.","journal-title":"Neuropsychopharmacol."},{"key":"381_CR6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4088\/JCP.v57n1203","volume":"57","author":"T Partonen","year":"1996","unstructured":"Partonen T, Sihvo S, Lonnqvist JK. Patients excluded from antidepressant efficacy trial. J Clin Psychiatry. 1996;57:572\u20135.","journal-title":"J Clin Psychiatry"},{"key":"381_CR7","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.4088\/JCP.v64n0915","volume":"64","author":"G Keitner","year":"2003","unstructured":"Keitner G, Posternak M, Ryan C. How many subjects with major depressive disorder meet eligibility requirements of an antidepressant efficacy trial? J Clin Psychiatry. 2003;64:1091\u20133.","journal-title":"J Clin Psychiatry"},{"key":"381_CR8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1176\/appi.ajp.159.3.469","volume":"159","author":"M Zimmerman","year":"2002","unstructured":"Zimmerman M, Mattia JI, Posternak MA. Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice. Am J Psychiatry. 2002;159:469\u201373.","journal-title":"Am J Psychiatry"},{"key":"381_CR9","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1017\/S0033291710002175","volume":"41","author":"R Lem van der","year":"2011","unstructured":"van der Lem R, van der Wee NJ, van Veen T, Zitman FG. The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice. Psychol Med. 2011;41:1353\u201363.","journal-title":"Psychol Med"},{"key":"381_CR10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1176\/appi.ajp.2008.08071027","volume":"166","author":"SR Wisniewski","year":"2009","unstructured":"Wisniewski SR, Rush AJ, Nierenberg AA, Gaynes BN, Warden D, Luther JF, et al. Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry. 2009;166:599\u2013607.","journal-title":"Am J Psychiatry"},{"key":"381_CR11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/JCP.0b013e318058263f","volume":"27","author":"M Zetin","year":"2007","unstructured":"Zetin M, Hoepner CT. Relevance of exclusion criteria in antidepressant clinical trials: a replication study. J Clin Psychopharmacol. 2007;27:295\u2013301.","journal-title":"J Clin Psychopharmacol"},{"key":"381_CR12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.nmd.0000110279.23893.82","volume":"192","author":"M Zimmerman","year":"2004","unstructured":"Zimmerman M, Chelminski I, Posternak M. Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples included. J Nerv Ment Dis. 2004;192:87\u201394.","journal-title":"J Nerv Ment Dis."},{"key":"381_CR13","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.mayocp.2015.06.016","volume":"90","author":"M Zimmerman","year":"2015","unstructured":"Zimmerman M, Clark HL, Multach MD, Walsh E, Rosenstein LK, Gazarian D. Have treatment studies of depression become even less generalizable?: a review of the inclusion and exclusion criteria in placebo controlled antidepressant efficacy trials published during the past 20\u00a0years. Mayo Clin Proceed. 2015;90:1180\u20136.","journal-title":"Mayo Clin Proceed."},{"key":"381_CR14","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jad.2005.02.018","volume":"87","author":"J Amsterdam","year":"2005","unstructured":"Amsterdam J, Shults J. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression\u2013lack of manic induction. J Affect Disord. 2005;87:121\u201330.","journal-title":"J Affect Disord"},{"key":"381_CR15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","volume":"60","author":"J Calabrese","year":"1999","unstructured":"Calabrese J, Bowden C, Sachs G, Ascher J, Monaghan E, Rudd G. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry. 1999;60:79\u201388.","journal-title":"J Clin Psychiatry."},{"key":"381_CR16","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","volume":"162","author":"J Calabrese","year":"2005","unstructured":"Calabrese J, Keck P, Macfadden W, Minkwitz M, Ketter T, Weisler R, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry. 2005;162:1351\u201360.","journal-title":"Am J Psychiatry"},{"key":"381_CR17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1399-5618.2007.00500.x","volume":"10","author":"J Calabrese","year":"2008","unstructured":"Calabrese J, Huffman R, White R, Edwards S, Thompson T, Ascher J, et al. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord. 2008;10:323\u201333.","journal-title":"Bipolar Disord"},{"key":"381_CR18","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jad.2004.09.009","volume":"85","author":"L Davis","year":"2005","unstructured":"Davis L, Bartolucci A, Petty F. Divalproex in the treatment of bipolar depression: a placebo-controlled study. J Affect Disord. 2005;85:259\u201366.","journal-title":"J Affect Disord"},{"key":"381_CR19","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4088\/JCP.v68n1203","volume":"68","author":"S Ghaemi","year":"2007","unstructured":"Ghaemi S, Gilmer W, Goldberg J, Zablotsky B, Kemp D, Kelley M, et al. Divalproex in the treatment of acute bipolar depression: a preliminary double-blind, randomized, placebo-controlled pilot study. J Clin Psychiatry. 2007;68:1840\u20134.","journal-title":"J Clin Psychiatry"},{"key":"381_CR20","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/JCP.0b013e31825ccde5","volume":"32","author":"I Lombardo","year":"2012","unstructured":"Lombardo I, Sachs G, Kolluri S, Kremer C, Yang R. Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial outcome? J Clin Psychopharmacol. 2012;32:470\u20138.","journal-title":"J Clin Psychopharmacol"},{"key":"381_CR21","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2013.13070984","volume":"171","author":"A Loebel","year":"2014","unstructured":"Loebel A, Cucchiaro J, Silva R, Kroger H, Hsu J, Sarma K, et al. Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study. Am J Psychiatry. 2014;171:160\u20138.","journal-title":"Am J Psychiatry"},{"key":"381_CR22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4088\/JCP.08m04942gre","volume":"71","author":"S McElroy","year":"2010","unstructured":"McElroy S, Weisler R, Chang W, Olausson B, Paulsson B, Brecher M, et al. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry. 2010;71:163\u201374.","journal-title":"J Clin Psychiatry"},{"key":"381_CR23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4088\/JCP.09m05570gre","volume":"72","author":"D Muzina","year":"2011","unstructured":"Muzina D, Gao K, Kemp D, Khalife S, Ganocy S, Chan P, et al. Acute efficacy of divalproex sodium versus placebo in mood stabilizer-naive bipolar I or II depression: a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry. 2011;72:813\u20139.","journal-title":"J Clin Psychiatry"},{"key":"381_CR24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jad.2014.07.007","volume":"168","author":"T Suppes","year":"2014","unstructured":"Suppes T, Datto C, Minkwitz M, Nordenhem A, Walker C, Darko D. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression. J Affect Disord. 2014;168:485\u201393.","journal-title":"J Affect Disord"},{"key":"381_CR25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.jcp.0000248603.76231.b7","volume":"26","author":"M Thase","year":"2006","unstructured":"Thase M, Macfadden W, Weisler R, Chang W, Paulsson B, Khan A, et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol. 2006;26:600\u20139.","journal-title":"J Clin Psychopharmacol"},{"key":"381_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/jcp.0b013e3181618eb4","volume":"28","author":"M Thase","year":"2008","unstructured":"Thase M, Jonas A, Khan A, Bowden C, Wu X, McQuade R, et al. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies. J Clin Psychopharmacol. 2008;28:13\u201320.","journal-title":"J Clin Psychopharmacol"},{"key":"381_CR27","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","volume":"60","author":"M Tohen","year":"2003","unstructured":"Tohen M, Vieta E, Calabrese J, Ketter T, Sachs G, Bowden C, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry. 2003;60:1079\u201388.","journal-title":"Arch Gen Psychiatry"},{"key":"381_CR28","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1192\/bjp.bp.112.108357","volume":"201","author":"M Tohen","year":"2012","unstructured":"Tohen M, McDonnell D, Case M, Kanba S, Ha K, Fang Y, et al. Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression. Br J Psychiatry. 2012;201:376\u201382.","journal-title":"Br J Psychiatry"},{"key":"381_CR29","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00213-014-3453-1","volume":"231","author":"M Wang","year":"2014","unstructured":"Wang M, Tong J, Huang D, Zhu G, Liang G, Du H. Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study. Psychopharmacology. 2014;231:2811\u20138.","journal-title":"Psychopharmacology"},{"key":"381_CR30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4088\/JCP.08m04995gre","volume":"71","author":"A Young","year":"2010","unstructured":"Young A, McElroy S, Bauer M, Philips N, Chang W, Olausson B, et al. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry. 2010;71:150\u201362.","journal-title":"J Clin Psychiatry"},{"key":"381_CR31","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"RC Young","year":"1978","unstructured":"Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429\u201335.","journal-title":"Br J Psychiatry"},{"key":"381_CR32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"381_CR33","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382\u20139.","journal-title":"Br J Psychiatry"},{"key":"381_CR34","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1399-5618.2007.00460.x","volume":"9","author":"FS Goes","year":"2007","unstructured":"Goes FS, Sadler B, Toolan J, Zamoiski RD, Mondimore FM, MacKinnon DF, et al. Psychotic features in bipolar and unipolar depression. Bipolar Disord. 2007;9:901\u20136.","journal-title":"Bipolar Disord"},{"key":"381_CR35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMsa065779","volume":"358","author":"EH Turner","year":"2008","unstructured":"Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358:252\u201360.","journal-title":"N Engl J Med"},{"key":"381_CR36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/ebmh.12.3.65","volume":"12","author":"SN Ghaemi","year":"2009","unstructured":"Ghaemi SN. The failure to know what isn\u2019t known: negative publication bias with lamotrigine and a glimpse inside peer review. Evid Based Ment Health. 2009;12:65\u20138.","journal-title":"Evid Based Ment Health."},{"key":"381_CR37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1192\/bjp.bp.112.120196","volume":"203","author":"M Koesters","year":"2013","unstructured":"Koesters M, Guaiana G, Cipriani A, Becker T, Barbui C. Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials. Br J Psychiatry. 2013;203:179\u201387.","journal-title":"Br J Psychiatry"},{"key":"381_CR38","doi-asserted-by":"crossref","first-page":"g1888","DOI":"10.1136\/bmj.g1888","volume":"348","author":"D Taylor","year":"2014","unstructured":"Taylor D, Sparshatt A, Varma S, Olofinjana O. Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies. BMJ. 2014;348:g1888.","journal-title":"BMJ"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-016-0381-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-016-0381-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-016-0381-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T21:00:31Z","timestamp":1498338031000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-016-0381-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,19]]},"references-count":38,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["381"],"URL":"https:\/\/doi.org\/10.1007\/s40263-016-0381-0","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,19]]}}}